PAA 2.63% 19.5¢ pharmaust limited

Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-428

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,342 Posts.
    lightbulb Created with Sketch. 2906
    The Association for Frontotemporal Degeneration has a generous funding program to assist in research.

    This one particularly caught my eye. No details on 2024 program timing, but 2023 grants were awarded in March. Up to USD$2M available :

    The Treat FTD Fund

    https://hotcopper.com.au/data/attachments/5915/5915552-d54286112681a6e2ed5fbaa67295b2e0.jpg
    https://hotcopper.com.au/data/attachments/5915/5915555-63b50e7b6e60aa112cd9c833842dc44d.jpg
    https://hotcopper.com.au/data/attachments/5915/5915557-edd6bb66781791b61b5d3519a9c31609.jpg

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.